Israel News App
ASTRO 2025: Genomic and Transcriptomic Profiling of Radiation Resistant, Locally Recurrent Prostate Cancer – UroToday
Written by
admin
in
6. Business
ASTRO 2025: Genomic and Transcriptomic Profiling of Radiation Resistant, Locally Recurrent Prostate Cancer
UroToday
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer
Medical…
Continue Reading